The Claim
In adults with essential hypertension, 8 weeks of treatment with 25 mg/day chlorthalidone causes a statistically significant reduction in plasma potassium levels, and this reduction is consistent with a diuretic-induced hypokalemia effect that resolves with combination therapy or dose adjustment.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with high blood pressure, taking 25 mg of chlorthalidone daily for 8 weeks lowers plasma potassium levels due to its diuretic effect, and this lowering can be reversed by adjusting the dose or combining it with other medications.
See the scientific wording
In adults with essential hypertension, 8 weeks of treatment with 25 mg/day chlorthalidone causes a statistically significant reduction in plasma potassium levels, indicating a consistent diuretic-induced hypokalemia effect that resolves with combination therapy or dose adjustment.
Chlorthalidone blocks sodium reabsorption in the kidney's early distal tubule, causing more sodium to flow to the collecting duct. This increases the electrical gradient that drives potassium out of the blood and into the urine, lowering blood potassium levels.
What the research says
1 studyTaking chlorthalidone for 8 weeks lowered potassium levels in the blood, just like the claim says, and the study shows this drop happened only in the first two months, not longer.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.